BioLife Sciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLFE research report →
Companywww.biolifesciences.com
Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. It offers disinfecting wipes, UV sterilization technology, electrostatic disinfection services, anti-microbial textiles, and touchless vending/marketplaces products.
- CEO
- Justin De Four
- IPO
- 2005
- Employees
- 3
- HQ
- Henderson, ON, CA
Price Chart
Valuation
- Market Cap
- $156.68K
- P/E
- -0.00
- P/S
- 0.38
- P/B
- -0.01
- EV/EBITDA
- -0.26
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -239.25%
- Op Margin
- -302.17%
- Net Margin
- -307.99%
- ROE
- 367.14%
- ROIC
- 248.80%
Growth & Income
- Revenue
- $411.69K · 0.00%
- Net Income
- $-1,268,000 · -111716.58%
- EPS
- $-0.02 · -24400.00%
- Op Income
- $-1,244,000
- FCF YoY
- -5207564.71%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -2290.12
- Avg Volume
- 7
Get TickerSpark's AI analysis on BLFE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BLFE Coverage
We haven't published any research on BLFE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BLFE Report →